104 related articles for article (PubMed ID: 4087035)
1. Clinical studies with ampligen (mismatched double-stranded RNA).
Brodsky I; Strayer DR; Krueger LJ; Carter WA
J Biol Response Mod; 1985 Dec; 4(6):669-75. PubMed ID: 4087035
[TBL] [Abstract][Full Text] [Related]
2. Preclinical studies with Ampligen (mismatched double-stranded RNA).
Carter WA; Strayer DR; Hubbell HR; Brodsky I
J Biol Response Mod; 1985 Oct; 4(5):495-502. PubMed ID: 4078595
[TBL] [Abstract][Full Text] [Related]
3. Comparative studies of ampligen (mismatched double-stranded RNA) and interferons.
Carter WA; Hubbell HR; Krueger LJ; Strayer DR
J Biol Response Mod; 1985 Dec; 4(6):613-20. PubMed ID: 2418160
[TBL] [Abstract][Full Text] [Related]
4. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
5. Ampligen inhibits human herpesvirus-6 in vitro.
Ablashi DV; Berneman ZN; Williams M; Strayer DR; Kramarsky B; Suhadolnik RJ; Reichenbach N; Hiltzges P; Komaroff AL
In Vivo; 1994; 8(4):587-91. PubMed ID: 7893986
[TBL] [Abstract][Full Text] [Related]
6. [Biological actions and therapeutic perspectives of double stranded polyribonucleotides: a reappraisal].
Thang MN; Guschlbauer W
Pathol Biol (Paris); 1992 Dec; 40(10):1006-14. PubMed ID: 1284399
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of Ampligen.
Brodsky I; Strayer DR
Am Fam Physician; 1987 Oct; 36(4):253-6. PubMed ID: 3673869
[No Abstract] [Full Text] [Related]
8. Clinical, immunological, and virological effects of ampligen, a mismatched double-stranded RNA, in patients with AIDS or AIDS-related complex.
Carter WA; Strayer DR; Brodsky I; Lewin M; Pellegrino MG; Einck L; Henriques HF; Simon GL; Parenti DM; Scheib RG
Lancet; 1987 Jun; 1(8545):1286-92. PubMed ID: 2884413
[TBL] [Abstract][Full Text] [Related]
9. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
Jasani B; Navabi H; Adams M
Vaccine; 2009 May; 27(25-26):3401-4. PubMed ID: 19200817
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
[TBL] [Abstract][Full Text] [Related]
11. Phase I clinical and pharmacokinetic study of plitidepsin as a 1-hour weekly intravenous infusion in patients with advanced solid tumors.
Izquierdo MA; Bowman A; García M; Jodrell D; Martinez M; Pardo B; Gómez J; López-Martin JA; Jimeno J; Germá JR; Smyth JF
Clin Cancer Res; 2008 May; 14(10):3105-12. PubMed ID: 18483378
[TBL] [Abstract][Full Text] [Related]
12. A safety and pharmacokinetic study of a mixed-backbone oligonucleotide (GEM231) targeting the type I protein kinase A by two-hour infusions in patients with refractory solid tumors.
Chen HX; Marshall JL; Ness E; Martin RR; Dvorchik B; Rizvi N; Marquis J; McKinlay M; Dahut W; Hawkins MJ
Clin Cancer Res; 2000 Apr; 6(4):1259-66. PubMed ID: 10778949
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
[TBL] [Abstract][Full Text] [Related]
16. Cyclic AMP mediates the direct antiproliferative action of mismatched double-stranded RNA.
Hubbell HR; Boyer JE; Roane P; Burch RM
Proc Natl Acad Sci U S A; 1991 Feb; 88(3):906-10. PubMed ID: 1846967
[TBL] [Abstract][Full Text] [Related]
17. Sensitivities of human glioma cell lines to interferons and double-stranded RNAs individually and in synergistic combinations.
Dick RS; Hubbell HR
J Neurooncol; 1987; 5(4):331-8. PubMed ID: 2450181
[TBL] [Abstract][Full Text] [Related]
18. Growth of astrocytomas in the human tumor clonogenic assay and sensitivity to mismatched dsRNA and interferons.
Strayer DR; Weisband J; Carter WA; Black P; Nidzgorski F; Cook AW
Am J Clin Oncol; 1987 Aug; 10(4):281-4. PubMed ID: 3039828
[TBL] [Abstract][Full Text] [Related]
19. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.
Giaccone G; Punt CJ; Ando Y; Ruijter R; Nishi N; Peters M; von Blomberg BM; Scheper RJ; van der Vliet HJ; van den Eertwegh AJ; Roelvink M; Beijnen J; Zwierzina H; Pinedo HM
Clin Cancer Res; 2002 Dec; 8(12):3702-9. PubMed ID: 12473579
[TBL] [Abstract][Full Text] [Related]
20. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
